| Date | Time | Source | Headline | Symbol | Company |
| 06/17/2024 | 8:14AM | Business Wire | WEBTOON Entertainment Announces Launch of Initial Public Offering Roadshow | | |
| 06/17/2024 | 8:11AM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:SLRX | Salarius Pharmaceuticals Inc |
| 06/17/2024 | 8:10AM | GlobeNewswire Inc. | Invesco Ltd: Form 8.3 - Crest Nicholson Holdings PLC_OPD | | |
| 06/17/2024 | 8:10AM | PR Newswire (US) | Multiple New Awards Recognize NCCN as Exceptional Source for Information for Cancer Patients and Caregivers | | |
| 06/17/2024 | 8:10AM | PR Newswire (US) | Nikon Z6 III Full Frame Mirrorless Camera Announced; YouTube Video First Look, Live Event and Learn More Info at B&H | | |
| 06/17/2024 | 8:10AM | PR Newswire (US) | Constructor Raises $25M Series B Led by Sapphire Ventures, Tripling Valuation to $550M | | |
| 06/17/2024 | 8:09AM | GlobeNewswire Inc. | Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure | | |
| 06/17/2024 | 8:08AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SLDPW | Solid Power Inc |
| 06/17/2024 | 8:08AM | PR Newswire (US) | Buzz Dealer Set to Make a Splash at iFX Expo International 2024 In Limassol | | |
| 06/17/2024 | 8:08AM | PR Newswire (US) | Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm | NASDAQ:FFNW | First Financial Northwest Inc |
| 06/17/2024 | 8:08AM | PR Newswire (US) | Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm | NASDAQ:HCP | HashiCorp Inc |
| 06/17/2024 | 8:08AM | PR Newswire (US) | Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm | NASDAQ:CALB | California BanCorp |
| 06/17/2024 | 8:08AM | PR Newswire (US) | Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm | NASDAQ:SRDX | SurModics Inc |
| 06/17/2024 | 8:07AM | GlobeNewswire Inc. | Invesco Ltd: Form 8.3 - Bellway PLC_OPD | | |
| 06/17/2024 | 8:07AM | PR Newswire (US) | La Roche-Posay is Proud to Host its 4th-Annual Pride In Dermatology Event Benefiting LGBTQ+ Nonprofits Homeward NYC and OutCare Health | | |
| 06/17/2024 | 8:07AM | PR Newswire (US) | Multiple New Awards Recognize NCCN as Exceptional Source for Information for Cancer Patients and Caregivers | | |
| 06/17/2024 | 8:07AM | PR Newswire (US) | Omdia reports booming demand for low-end smartphones priced under $150 | | |
| 06/17/2024 | 8:06AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:DOCN | DigitalOcean Holdings Inc |
| 06/17/2024 | 8:06AM | Business Wire | OQ Chemicals erhält ISCC Plus-Zertifizierung für seinen Standort in Bay City, Texas | | |
| 06/17/2024 | 8:06AM | Business Wire | Wolters Kluwer AI-powered advanced virtual agent ushers in the next generation of customer support | | |
| 06/17/2024 | 8:06AM | Business Wire | OQ Chemicals’ Bay City Site Attains ISCC Plus Sustainability Certification | | |
| 06/17/2024 | 8:06AM | PR Newswire (US) | Amsted Automotive Team to Lead Metallurgy and Vehicle Electrification Panels and Discussions at PowderMet2024 | | |
| 06/17/2024 | 8:06AM | Business Wire | Tamboran Resources Corporation Announces Launch of Initial Public Offering | | |
| 06/17/2024 | 8:05AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ENBP | ENB Financial Corporation (QX) |
| 06/17/2024 | 8:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SLRX | Salarius Pharmaceuticals Inc |
| 06/17/2024 | 8:05AM | Business Wire | Agilysys Golf, Used by 13 of the Top 20 Resort Courses in the U.S., To Be Demonstrated at HITEC 2024 June 24 -27 | NASDAQ:AGYS | Agilysys Inc |
| 06/17/2024 | 8:05AM | PR Newswire (US) | BrightStar Care® Receives Prestigious Fast 50 Award from Crain's Chicago Business | | |
| 06/17/2024 | 8:05AM | Business Wire | Delve Bio Announces Clinical Data on the Use of Metagenomic Next-Generation Sequencing (mNGS) to Identify Pathogens Causing Central Nervous System Infections | | |
| 06/17/2024 | 8:05AM | GlobeNewswire Inc. | Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s Disease | NASDAQ:IKT | Inhibikase Therapeutics Inc |
| 06/17/2024 | 8:05AM | PR Newswire (US) | Day Zero Diagnostics Presents Direct-From-Blood, Rapid Antimicrobial Susceptibility Testing at ASM Microbe | | |